MiMedx Group
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, MiMedx Group sits in the top decile of US sponsors by registered trial count (#513 of 15,742 sponsors by registered trial count).
MiMedx Group: 32 sponsored US clinical trials, 1 recruiting.
MiMedx Group sponsors 32 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 26 completed. 2 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Scarring, with 2 trials.
Top-decile sponsor footprint
MiMedx Group ranks in the top decile of sponsors by registered trial count (#513 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
26 of 31 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
32 total, page 1 of 1
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
NCT06600724
Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis
NCT05796765
Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee
NCT03485157
Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy
NCT03479463
Use of Human Dehydrated Amnion Chorion Allograft in Closed Hemorroidectomy
NCT03479489
Micronized dHACM Injectable for the Treatment of Achille Tendonitis
NCT03414255
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
NCT03414268
A Single Center, Prospective, Case Series of the Treatment of Pressure Ulcers and Decubitus Ulcers.
NCT03529578
Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy
NCT03323021
Use of Human Dehydrated Umbilical Cord Allograft in Supraspinatus Tendon Repair
NCT03084068
Protocol for the Clinical Evaluation of Lyophilized Amniotic Fluid in the Treatment of Knee Osteoarthritis
NCT03074526
Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers
NCT02844660
Case Series of Weekly Applications of dHACM in Treatment of Pressure Ulcers
NCT02861560
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
NCT02768155
Dehydrated Human Amnion Chorion Membrane (dHACM) vs. Control in the Treatment of Partial Thickness Burns.
NCT02765737
DHACM in Robotic Assisted Laparoscopic Prostatectomy (RALP)
NCT02526173
dHACM Mesh In the Treatment of Diabetic Foot Ulcers
NCT02589210
Micronized dHACM Injectable for the Treatment of Plantar Fasciitis
NCT02427191
dHACM in Lumbar Decompression and Microdiscectomy Surgery
NCT02300909
Amniotic Membrane in Decompressive Craniectomy to Reduce Scarring
NCT02033824
Use of dHACM in the Treatment of Venous Leg Ulcers
NCT02011503
Amniotic Membrane in Total Knee Replacements to Reduce Scarring
NCT02088567
Dehydrated Human Amnion/Chorion Membrane Micrografts(dHACM) Injectable in the Treatment of Recalcitrant Plantar Fasciitis
NCT01996111
DHACM vs Other Commercially Available Treatments
NCT01921491
Micronized Dehydrated Human Amniotic Membrane Suspension in the Treatment of Lateral Epicondylitis
NCT01921569
Randomized Clinical Trial Using Amniotic Membrane in Robotic Assisted Laparoscopic Prostatectomy
NCT01832168
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
NCT01659827
Comparative Study of Two Application Regimens of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
NCT01657474
Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot Ulcers
NCT01693133
Comparative Study of Amniotic Membrane Wound Graft In the Management of Diabetic Foot Ulcers
NCT01552499
Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers
NCT01552447
An Evaluation of the Effect of the AmnioFix Amniotic Membrane Allograft in Patients Undergoing Posterior Instrumentation Removal
NCT01357187
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 2 |
Therapeutic Areas
What is open in the MiMedx Group pipeline
1 recruiting of 32 indexed (3% open); 26 completed (81%).
Phase mix: 2 late (III/IV) vs 3 early (I/II) (balanced across stages).
Top condition: Scarring (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
MiMedx Group: open-pipeline peers nationwide
Peers matched on 32 registered trials and 3% open enrollment, not the therapeutic-area sidebar.
MiMedx Group sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 32 trials (± recruiting share)
- Aerie Pharmaceuticals · 32 trials · 0% recruiting
- Allina Health System · 32 trials · 3% recruiting
- Ardea Biosciences · 32 trials · 0% recruiting
- Hebrew SeniorLife · 32 trials · 19% recruiting
Sponsors near 3% open enrollment (± trial volume)
- CooperVision · 3% recruiting · 64 trials
- Masimo Corporation · 3% recruiting · 96 trials
- Sharp HealthCare · 3% recruiting · 32 trials
- Aclaris Therapeutics · 3% recruiting · 33 trials
Related
What to do with this MiMedx Group page
32 registered trials is a research-attention snapshot, not an endorsement of MiMedx Group or any single study.
- 1 of MiMedx Group's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Scarring is the condition MiMedx Group studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Scarring trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
MiMedx Group pipeline card: 32 registered trials from official public datasets.Report a data error.